Report

ENT Handheld Instruments Market By Product Type (Otology Instruments, Rhinology Instruments, And Laryngeal Instruments), By End User (Hospitals, Specialty Clinics, And Ambulatory Surgical Centers), and by geography is expected to grow at a steady CAGR forecast till 2027 owing to the increase in surgeries due to rise in prevalence of ENT disorders such as hearing loss and thryoid cancer.



Global ENT Handheld Instruments Market is expected to grow at a CAGR of 6.36% during the forecast period from 2022 to 2027. The demand for ENT handheld instruments is primarily being boosted by increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, and rising geriatric population, all these collectively contributing in the growth of the ENT handheld instruments market during the forecast period from 2022-2027.

ENT Handheld Instruments Market Dynamics:
The ENT handheld instruments market is witnessing a growth in product demand owing to numerous factors, one of them being the increasing number of cases of hearing loss due to different causes. As per the latest data provided by the World Health Organization, as of April 2021, near about 430 million people suffer from varying degrees of hearing loss. The factsheet further stated that by 2050, approximately 2.5 billion people are estimated to be affected with some degree of hearing loss. Ear surgeries such as eardrum repair (tympanoplasty), ear tube placement, and stapedectomy are some of the common procedures conducted in the ENT specialty for which ENT handheld instruments are extensively used. Therefore, the rising prevalence of hearing loss would result in the increase in the volume of such procedures, which being performed to restore hearing capacity in patients, which in turn driving the global ENT handheld instruments market growth during the forecast period from 2022-2027.



Another key factor contributing in the growth of the global ENT handheld instruments market is the rising prevalence of thyroid cancer. As per the GLOBOCAN 2020 data, in 2020, nearly 586,202 new cases of thyroid cancer were diagnosed across the globe. One of the treatment methods for thyroid cancer is thyroidectomy in which the thyroid gland is either partially or fully removed. This is done with the help of various ENT handheld instruments that are employed during the procedure. Thus, the increase in the prevalence of thyroid cancer would result in the increase in the number of thryoidectomies being performed, eventually contributing in the growth of the ENT handheld instruments market during the forecast period.



However, limited awareness regarding ENT disorders and treatments in emerging economies and the constant need for sterilizing the ENT handheld surgical instruments may be certain impeding factors to ENT handheld instruments market growth.



In addition to the previously mentioned factors, the ENT handheld instruments market witnessed a period of temporary setback due to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for ENT handheld instruments in the market as various procedures pertaining to ENT specialty were deemed non-essential during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for ENT handheld instruments is on the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the ENT handheld instruments market during the forecast period

ENT Handheld Instruments Market Segment Analysis:
ENT Handheld Instruments Market by Product Type (Otology Instruments, Rhinology Instruments, and Laryngeal Instruments), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).



In the product segment of the ENT Handheld Instruments Market, the otology instruments category is estimated to hold a significant share in the forecast period. This can be ascribed to the rising prevalence of ear-related ailments such as age- related hearing loss in elderly, otitis media particularly in pediatric population, cases of vertigo and dizziness, and tinnitus among others compared to indications associated with rhinology and laryngology. Therefore, the increase in the prevalence of ear-related ailments are expected to drive the demand for otology-related handheld devices, which in turn would result in the growth of the overall the ENT handheld instruments market during the forecast period (2022-2027).

North America is expected to dominate the Overall ENT Handheld Instruments Market:
Among all the regions, North America is expected to account for the largest share in the ENT handheld instruments market. Owing to significant growth factors such as surging cases of obstructive sleep apnea, increasing prevalence of sinusitis, increasing geriatric population, and rising government initiatives for creating awareness regarding hearing loss prevalence and treatment are expected to aid in the growth of the North America ENT Handheld Instruments Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.



As per the data provided by the Centers for Disease Control and Prevention (CDC) in 2020, near about 28.9 million adults were diagnosed with sinusitis in the United States. Moreover, the information provided by the World Allergy Organization (2021), the prevalence of chronic sinusitis is usually in the range of 12% in the United States. Chronic sinusitis can cause major trouble in breathing and sinus surgery is often recommended in patients that are refractory to medications and other therapies. Therefore, with the presence of high patient pool of chronic sinusitis patients in the country, it is estimated that there may be an increase in the number of procedures of sinus surgery being performed that may in turn drive the demand for ENT handheld instruments, thereby supporting the growth of the United States ENT handheld instruments market during the forecast period.



Furthermore, according to the American Sleep Apnea Association (2021), currently an estimated number of 22 million Americans suffer from obstructive sleep apnea. Even though positive airway pressure (PAP) therapy is the gold standard OSA treatment, it has been observed that the patient compliance with PAP therapy can be low due to various factors as well as PAP therapy being ineffective in other set of patients. Therefore, in such patients, surgeries are recommended which are focused on correcting the structural defects in the nose, throat, and upper respiratory tract. Thus, owing to the increasing prevalence of OSA in the country, the demand for ENT handheld instruments may witness an increase in the United States, resulting in the growth of the United States ENT handheld instruments market as well as the North America ENT handheld instruments market.

ENT Handheld Instruments Market Key Players:
Some of the key market players operating in the ENT handheld instruments market includes Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated and others.

Recent Developmental Activities in ENT Handheld Instruments Market:
- In August 2021, Medtronic announced the acquisition of a company with an extensive ENT portfolio- Intersect ENT for approximately USD 1.1 billion.
- In May 2020, Stryker announced the acquisition of Entellus Medical Inc in order to include the XpRESS products to their ENT product offerings.
- In February 2019, Stryker announced the acquisition of Arrinex Inc thereby enabling Stryker to include the Clarifix device to their ENT product portfolio.
Key Takeaways from the ENT Handheld Instruments Market Report Study
- Market size analysis for current ENT handheld instruments market size (2020), and market forecast for 5 years (2022-2027)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ENT handheld instruments market.
- Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
- Key companies dominating the Global ENT Handheld Instruments Market.
- Various opportunities available for the other competitor in the ENT Handheld Instruments Market space.
- What are the top performing segments in 2021? How these segments will perform in 2027.
- Which is the top-performing regions and countries in the current ENT handheld instruments market scenario?
- Which are the regions and countries where companies should have concentrated on opportunities for ENT handheld instruments market growth in the coming future?
Target Audience who can be benefited from this ENT Handheld Instruments Market Report Study
- ENT Handheld Instruments products providers
- Research organizations and consulting companies
- ENT Handheld Instruments-related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and Traders dealing in ENT handheld instruments
- Various End-users who want to know more about the ENT Handheld Instruments market and latest technological developments in the ENT Handheld Instruments market.
Frequently Asked Questions for ENT Handheld Instruments Market:
1. What is an ENT Handheld Instrument?

An ENT handheld instrument is a device which are majorly employed during various ENT surgeries and specialized according to the structure being operated on such as otology-handheld instruments, rhinology instruments, and others.



2. What is the market for Global ENT Handheld Instruments?

Global ENT Handheld Instruments Market is expected to grow at a CAGR of 6.36% during the forecast period from 2022-2027.



3. What are the drivers for Global ENT Handheld Instruments Market?

The demand for ENT handheld instruments is primarily being boosted by increasing prevalence of hearing loss, increasing prevalence of thyroid cancer, rising number of cases of sinusitis, and rising geriatric population thereby contributing in the growth of the ENT handheld instruments market in the forecast period.



4. Who are the key players operating in Global ENT Handheld Instruments Market?

Some of the key market players operating in the ENT handheld instruments market includes Integra Lifesciences, Stryker, Medtronic, SPIGGLE & THEIS Medizintechnik GmbH, Olympus, PRO-MED Instrumente GmbH, B. Braun Melsungen AG, Grace Medical, Heinz Kurz GmbH, Summit Medical LLC, Advin Healthcare, FENTEX medical GmbH., Rica Surgical Products, Inc., BLINK MEDICAL, Symmetry Surgical Inc., Bailey Instruments Ltd, Tonglu WANHE Medical Instrument Co.,Ltd, Moonlight Surgical Works, SOLCO BIOMEDICAL CO., LTD, ELMED Incorporated, BD, Teleflex Incorporated and others.



5. Which region has the highest share in ENT Handheld Instruments market?

North America is expected to dominate the overall ENT Handheld Instruments market during the forecast period, 2022-2027. Owing to significant growth factors such as surging cases of obstructive sleep apnea, increasing prevalence of sinusitis, increasing geriatric population, and rising government initiatives for creating awareness regarding hearing loss prevalence and treatment are expected to aid in the growth of the North America ENT Handheld Instruments Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.